SpeakersProfessor Andrew Hattersley, FRSM, Peninsula Medical School (PMS), Dr. Maggie Shepherd, PMS, Professor Neil Avent, University of Plymouth and Dr. Daniela Bezemer, HIV Monitoring Foundation, Academic Medical Centre, Amsterdam.
Organised byDr Susan Kelly, Senior Research Fellow, Egenis, University of Exeter
Egenis, Byrne House, Streatham Campus, University of Exeter
This is the third workshop in this EGN Workstream, .
What impacts of genomic subclassification on disease management and clinical medicine are following from our increasing ability to stratify and classify biological states genomically? We will look at specific instances of health system responses to genetic heterogeneity of disease within populations to evaluate what lessons can be drawn, and what measure - in terms education, infrastructure, investment in research and/or technology, and policy health systems - might improve disease management. We will begin with an examination of the identification of significant genomic subpopulations with diabetes, and impacts on clinical management. We will go on to consider what implications for health systems follow from research into the genomics of common complex diseases. How are different health systems placed to respond to genetic heterogeneity in high impact diseases such as HIV/AIDS? What challenges are faced at the EU level in efforts to introduce innovations such as mass-scale genotyping of blood donors, an area of high genetic heterogeneity and impact on health care practices and health? How are advances in genetic immunotyping changing or challenging organ transplantation practices?
09:30 – 10:00 am coffee 10:00 – 10:15 Welcome and introduction – Dr. Susan Kelly10:15 – 11:00 Dr. Maggie Shepherd, PCMD ‘Increasing awareness of monogenic diabetes’11:00 – 11:45 Professor Andrew Hattersley, PCMD ‘Using sequencing to improve health care in diabetes - should we be sequencing the whole genome?’11:45 – 12:15 Tea/coffee break12:15 – 12:45 Respondent and discussion 12:45 – 1:45 Lunch1:45 – 2:30 Professor Neil Avent, University of Plymouth, ‘Mass scale blood group genotyping- clinical implications’2:30 – 3:15 Dr. Daniela Bezemer, HIV Monitoring Foundation, Academic Medical Centre, Amsterdam ‘Genomic subpopulations and experience of HIV monitoring’3:15 – 3:45 Tea/coffee break3:45 – 4:30 Respondent (Dr. James Mittra) and discussion 4:30 – 5:00 Further seminar wide discussion of issues, and close